NCT03984097 2026-03-10A Study to Evaluate Subcutaneous TAK-079 Added to Standard of Care Regimens in Participants With Newly Diagnosed Multiple Myeloma (NDMM)TakedaPhase 1 Active not recruiting50 enrolled
NCT02542657 2024-09-19Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple MyelomaUniversity of California, DavisPhase 1/2 Active not recruiting30 enrolled